Sign Out
Hypersensitivity to felodipine or any component of the product.
History of previous allergic reaction to other dihydropyridine calcium channel blockers because of theoretical risk of cross-reactivity.
Clinically significant aortic stenosis.
Uncompensated heart failure.
Acute myocardial infarction.
Unstable angina pectoris.
As with other calcium channel blockers, felodipine should be discontinued in patients who develop cardiogenic shock.
Pregnancy.
Continue with Google